|Articles|July 15, 2002
- BioPharm International-07-01-2002
- Volume 15
- Issue 7
Inside Washington: One Hundred Years of Biotech Regulation
Author(s)Jill Wechsler
by Jill Wechsler, CBER is heralding its rich regulatory history while preparing to tackle new scientific and administrative challenges.
Advertisement
Articles in this issue
over 23 years ago
Facilitating Client Audits: The Contract Laboratory Perspectiveover 23 years ago
Knowledge Management: The Four Pillars of Successover 23 years ago
Guest Editorial: Supreme Court Rules on FestoNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Strategic Shifts for Speed, Resilience, and Long-Term Sustainability in Biomanufacturing
2
Why Data Quality, Not Regulation, Is the True Barrier to AI in Biologics
3
Advances in Continuous Manufacturing, Drug Delivery Lead CPHI Pharma Awards 2025
4
EU Biopharma Strategy: Scaling Up to Tackle Funding Gaps and Drive Innovation
5
